Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Amortization of Deferred Charges (2016 - 2025)

Historic Amortization of Deferred Charges for Tandem Diabetes Care (TNDM) over the last 12 years, with Q3 2025 value amounting to $444000.0.

  • Tandem Diabetes Care's Amortization of Deferred Charges fell 1155.38% to $444000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year decrease of 788.46%. This contributed to the annual value of $2.1 million for FY2024, which is 521.78% down from last year.
  • Tandem Diabetes Care's Amortization of Deferred Charges amounted to $444000.0 in Q3 2025, which was down 1155.38% from $465000.0 recorded in Q2 2025.
  • In the past 5 years, Tandem Diabetes Care's Amortization of Deferred Charges registered a high of $702000.0 during Q3 2023, and its lowest value of $428000.0 during Q1 2021.
  • Moreover, its 5-year median value for Amortization of Deferred Charges was $493000.0 (2023), whereas its average is $491052.6.
  • Per our database at Business Quant, Tandem Diabetes Care's Amortization of Deferred Charges tumbled by 8873.93% in 2021 and then soared by 4068.14% in 2023.
  • Tandem Diabetes Care's Amortization of Deferred Charges (Quarter) stood at $435000.0 in 2021, then rose by 15.17% to $501000.0 in 2022, then fell by 1.6% to $493000.0 in 2023, then rose by 1.83% to $502000.0 in 2024, then dropped by 11.55% to $444000.0 in 2025.
  • Its Amortization of Deferred Charges was $444000.0 in Q3 2025, compared to $465000.0 in Q2 2025 and $505000.0 in Q1 2025.